Publicaciones en las que colabora con Beatriz Díaz Molina (15)

2021

  1. Spanish Heart Transplant Registry. 32nd Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 962-970

2020

  1. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1424-1437

  2. Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 919-926

2019

  1. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

2018

  1. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462

2015

  1. Donor/recipient sex mismatch and survival after heart transplantation: Only an issue in male recipients? An analysis of the Spanish Heart Transplantation Registry

    Transplant International, Vol. 28, Núm. 3, pp. 305-313

  2. First report of the Spanish Post-Heart-Transplant Tumor Registry

    Revista Espanola de Cardiologia Suplementos, Vol. 15, Núm. S2, pp. 50-57

  3. Impact of clinical profile of donor, recipient, and ischemia time on survival of heart transplant patients. Subanalysis of the Spanish Heart Transplantation Registry

    Cirugia Cardiovascular, Vol. 22, Núm. 6, pp. 279-286

2014

  1. The falling incidence of hematologic cancer after heart transplantation

    Clinical Transplantation, Vol. 28, Núm. 10, pp. 1142-1147

  2. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?

    International Journal of Cardiology, Vol. 171, Núm. 1, pp. 15-23

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

  2. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation

    Clinical Transplantation, Vol. 27, Núm. 6

2012

  1. Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 31, Núm. 3, pp. 288-295

2011

  1. Lung cancer after heart transplantation: Results from a large multicenter registry

    American Journal of Transplantation, Vol. 11, Núm. 5, pp. 1035-1040

2010

  1. Prevalence and severity of renal dysfunction among 1062 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: Results from the CAPRI study

    Clinical Transplantation, Vol. 24, Núm. 4